Literature DB >> 4351588

Interaction of lymphoid and nonlymphoid cells with the lymphocytosis-promoting factor of Bordetella pertussis.

A Adler, S I Morse.   

Abstract

The activity of soluble lymphocytosis-promoting factor (LPF) from Bordetella pertussis decreased after brief in vitro incubation with lymphoid cells or erythrocytes. The LPF activity was found to be associated with the cells used, and injection of the cells produced a leukocytosis and lymphocytosis which completely accounted for the loss of soluble activity. Attachment of LPF to cells was found to be reversible in vitro. It is suggested that reversible binding occurs in vivo.

Entities:  

Mesh:

Year:  1973        PMID: 4351588      PMCID: PMC422700          DOI: 10.1128/iai.7.3.461-467.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  8 in total

1.  Studies on lymphocytes 18. Mechanism of lymphocytosis induced by supernatant fluids of Bordetella pertussis cultures.

Authors:  K R Rai; A D Chanana; E P Cronkite; D D Joel; J B Stevens
Journal:  Blood       Date:  1971-07       Impact factor: 22.113

2.  Effects of the lymphocytosis-promoting factor from Bordetella pertussis on the function and potentiality of lymphocytes. I. Effect on the ability of lymphocytes to recirculate in the body.

Authors:  S Iwasa; T Yoshikawa; K Fukumura; M Kurokawa
Journal:  Jpn J Med Sci Biol       Date:  1970-02

3.  Studies on the leukocytosis and lymphocytosis induced by Bordetella pertussis. I. Radioautographic analysis of the circulating cells in mice undergoing pertussis-induced hyperleukocytosis.

Authors:  S I Morse; S K Riester
Journal:  J Exp Med       Date:  1967-03-01       Impact factor: 14.307

4.  A preliminary report on the neutralization of the lymphocytosis-promoting factor (LPF) with anti-LPF serum.

Authors:  S Ishida; S Asakawa; M Kurokawa
Journal:  Jpn J Med Sci Biol       Date:  1970-02

5.  The occurrence and properties of leukocytosis and lymphocytosis-stimulating material in the supernatant fluids of Bordetella pertussis cultures.

Authors:  S I Morse; K K Bray
Journal:  J Exp Med       Date:  1969-03-01       Impact factor: 14.307

6.  Studies on the leukocytosis and lymphocytosis induced by Bordetella pertussis. 3. The distribution of transfused lymphocytes in pertussis-treated and normal mice.

Authors:  S I Morse; B A Barron
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

7.  STUDIES ON THE LYMPHOCYTOSIS INDUCED IN MICE BY BORDETELLA PERTUSSIS.

Authors:  S I MORSE
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307

8.  Studies on the leukocytosis and lymphocytosis induced by Bordetella pertussis. II. The effect of pertussis vaccine on the thoracic duct lymph and lymphocytes of mice.

Authors:  S I Morse; S K Riester
Journal:  J Exp Med       Date:  1967-04-01       Impact factor: 14.307

  8 in total
  6 in total

1.  Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge model.

Authors:  J B Bruss; G R Siber
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

Review 2.  Pertussis leukocytosis: mechanisms, clinical relevance and treatment.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2016-09-07       Impact factor: 3.166

Review 3.  Novel therapies for the treatment of pertussis disease.

Authors:  Karen M Scanlon; Ciaran Skerry; Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2015-09-21       Impact factor: 3.166

4.  Effect of monoclonal antibody to pertussis toxin on toxin activity.

Authors:  H Sato; Y Sato; A Ito; I Ohishi
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

5.  The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes. I. Proliferative response.

Authors:  A S Kong; S I Morse
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

Review 6.  Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines.

Authors:  Kevin Markey; Catpagavalli Asokanathan; Ian Feavers
Journal:  Toxins (Basel)       Date:  2019-07-17       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.